Results 281 to 290 of about 7,259,671 (332)

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Lower limb muscle activation and biomechanics during single-leg hopping in different directions. [PDF]

open access: yesFront Sports Act Living
Gu Y   +6 more
europepmc   +1 more source

Improving Clinical Patient Activation and Strengthening Health Outcomes: Findings from a Quasi-Experimental Study. [PDF]

open access: yesJ Clin Med
Alsaad SM   +7 more
europepmc   +1 more source

Additional file 13 of Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in aggressive thyroid cancer

open access: green
Udinotti, Mario   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy